Amendment to Officer Loan AgreementOfficer Loan Agreement • August 16th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
Contract Type FiledAugust 16th, 2024 Company IndustryThis Amendment (the “Amendment”), effective August 16, 2024, is entered into between Kairos Pharma Ltd., a Delaware corporation (the “Company”), and Doug Samuelson (“Holder”). Such terms not otherwise defined herein shall have the meaning ascribed in the Notes (as defined below).
Portions of this agreement have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. Redactions are indicated with “[***].” Master Service and Technology AgreementMaster Service and Technology Agreement • August 16th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledAugust 16th, 2024 Company Industry Jurisdiction
Amendment to Officer Loan AgreementOfficer Loan Agreement • August 16th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
Contract Type FiledAugust 16th, 2024 Company IndustryThis Amendment (the “Amendment”), effective August 16, 2024, is entered into between Kairos Pharma Ltd., a Delaware corporation (the “Company”), and Neil Bhowmick (“Holder”). Such terms not otherwise defined herein shall have the meaning ascribed in the Notes (as defined below).
Amendment to Officer Loan AgreementOfficer Loan Agreement • August 16th, 2024 • Kairos Pharma, LTD. • Pharmaceutical preparations
Contract Type FiledAugust 16th, 2024 Company IndustryThis Amendment (the “Amendment”), effective August 16, 2024, is entered into between Kairos Pharma Ltd., a Delaware corporation (the “Company”), and John S. Yu (“Holder”). Such terms not otherwise defined herein shall have the meaning ascribed in the Notes (as defined below).